Resultats de la cerca - Quan‐Sing Ng
- Mostrar 1 - 11 resultats de 11
-
1
EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients per Natalia Sutiman, Shao Weng Tan, Eng Huat Tan, Wan‐Teck Lim, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Mei‐Kim Ang, Wan Ling Tan, Chee‐Keong Toh, Balram Chowbay
Publicat 2016Artigo -
2
A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma per Wan‐Teck Lim, Quan‐Sing Ng, Percy Ivy, Swan-Swan Leong, Onkar Singh, Balram Chowbay, Fei Gao, Choon Hua Thng, Boon-Cher Goh, Daniel Shao-Weng Tan, Tong San Koh, Chee‐Keong Toh, Eng-Huat Tan
Publicat 2011Artigo -
3
Intertumor heterogeneity of non‐small‐cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics per Daniel S.W. Tan, Sophie Camilleri‐Bröet, Eng Huat Tan, Marco Alifano, Wan‐Teck Lim, Antonio Bobbio, Shenli Zhang, Quan‐Sing Ng, Mei‐Kim Ang, N. Gopalakrishna Iyer, Angela Takano, Kiat Hon Lim, Jean‐François Régnard, Patrick Tan, Philippe Broët
Publicat 2014Artigo -
4
ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemot... per Mitchell R. Smith, Chris Parker, Fred Saad, K. Miller, Bertrand Tombal, Quan Sing Ng, Martin Bögemann, В. Б. Матвеев, Josep M. Piulats, Luis Eduardo Rosa Zucca, Axel Heidenreich, Yoshiyuki Kakehi, A. Zhang, Heiko Krissel, Jiayu Shen, V. Wagner, Celestia S. Higano
Publicat 2018Artigo -
5
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC) per Wai Meng David Tai, Wei Peng Yong, Cindy Lim, Lauren Low, Chee Kian Tham, Tong San Koh, Quan Sing Ng, W.W. Wang, L.Z. Wang, Septian Hartano, Choon Hua Thng, Hung Huynh, Kok-Hing Lim, Han Chong Toh, Boon Cher Goh, Su Pin Choo
Publicat 2016Artigo -
6
Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck... per Bhumsuk Keam, Jean-Pascal Machiels, Hye Ryun Kim, Lisa Licitra, Wojciech Golusiński, Vincent Grégoire, Y.G. Lee, Claus Belka, Ye Guo, Senthil Rajappa, Makoto Tahara, M. Azrif, Mei‐Kim Ang, Muh‐Hwa Yang, C.-H. Wang, Quan Sing Ng, W.I. Wan Zamaniah, Naomi Kiyota, S. Babu, Kaili Yang, Giuseppe Curigliano, Solange Peters, T.W. Kim, Takayuki Yoshino, George Pentheroudakis
Publicat 2021Artigo -
7
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC per Aaron C. Tan, A. Seet, Gillianne Lai, Tse Hui Lim, Alvin S.T. Lim, Gek San Tan, Angela Takano, David Tai, Tira J. Tan, Justina Yick Ching Lam, Matthew Chau Hsien Ng, Wan Ling Tan, Mei‐Kim Ang, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Tanujaa Rajasekaran, Wan‐Teck Lim, Eng-Huat Tan, Tony Kiat Hon Lim, Daniel S.W. Tan
Publicat 2020Artigo -
8
Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma per Wan‐Teck Lim, Hsiang‐Fong Kao, Lisda Suteja, Constance H. Li, Hong Sheng Quah, Daniel S.W. Tan, Sze Huey Tan, Eng-Huat Tan, Wan-Ling Tan, Justina Nadia Lee, Felicia Yu-Ting Wee, Amit Jain, Boon Cher Goh, Melvin L.K. Chua, Bin-Chi Liao, Quan Sing Ng, Ruey‐Long Hong, Mei‐Kim Ang, Joe Yeong, N. Gopalakrishna Iyer
Publicat 2023Artigo -
9
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung c... per Aaron C. Tan, Gillianne Lai, Stephanie P.L. Saw, Kevin Lee Min Chua, Angela Takano, Boon‐Hean Ong, Tina Koh, Amit Jain, Wan Ling Tan, Quan Sing Ng, Ravindran Kanesvaran, Tanujaa Rajasekaran, Ekaterina Kalashnikova, Derrick Renner, Sumedha Sudhaman, Meenakshi Malhotra, Himanshu Sethi, Minetta C. Liu, Alexey Aleshin, Wan‐Teck Lim, Eng‐Huat Tan, Anders J. Skanderup, Mei‐Kim Ang, Daniel S.W. Tan
Publicat 2024Artigo -
10
Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer per Stephanie P.L. Saw, Siqin Zhou, Jianbin Chen, Gillianne Lai, Mei‐Kim Ang, Kevin Lee Min Chua, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Wan Ling Tan, Tanujaa Rajasekaran, Wan‐Teck Lim, Aaron C. Tan, Kam Weng Fong, Angela Takano, Xin Cheng, Kiat Hon Lim, Tina Koh, Boon‐Hean Ong, Eng Huat Tan, Chee‐Keong Toh, Anders J. Skanderup, Sze Huey Tan, Daniel Shao-Weng Tan
Publicat 2021Artigo -
11
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial per Anthony T.�C. Chan, V.H.F. Lee, R-L. Hong, M-J. Ahn, Wan Qin Chong, S. B. Kim, Gwo Fuang Ho, Priscilla B. Caguioa, Nuttapong Ngamphaiboon, Cheryl Ho, Mubashir Aziz, Quan Sing Ng, C-J. Yen, Nopadol Soparattanapaisarn, Roger KC Ngan, S.K. Kho, M.L.A. Tiambeng, Tak Yun, Virote Sriuranpong, Alain P. Algazi, Andy S. K. Cheng, Erminia Massarelli, Ramona F. Swaby, Sanatan Saraf, Jianda Yuan, Lillian L. Siu
Publicat 2022Artigo
Eines de cerca:
Matèries relacionades
Internal medicine
Medicine
Oncology
Cancer
Biology
Gastroenterology
Gene
Lung cancer
Surgery
Biochemistry
Cancer research
Pathology
Chemistry
Chemotherapy
Clinical endpoint
Clinical trial
Colorectal cancer
Confidence interval
Epidermal growth factor receptor
Genetics
Hazard ratio
Nasopharyngeal carcinoma
Paleontology
Phases of clinical research
Radiation therapy
Receptor
Retrospective cohort study
Stage (stratigraphy)
Urology
Abiraterone acetate